Explain this page
Arphra AIPlain-English read on Johnson & Johnson’s valuationCompany profile
DB · companies + sec_company_profile + company_profilesJohnson & Johnson (JNJ) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolJNJ
- Legal nameJohnson & Johnson
- CEO—
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CountryUS
- CurrencyUSD
- ExchangeNYSE
- IPO date—
- CIK0000200406
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$546.9B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge market-data, SEC, and non-US sources.
- FIGIBBG000BMHYD1
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Joaquin Duato | Chief Executive Officer & Chairman | $6.5M | 1963 | — |
| Jennifer L. Taubert | Executive Vice President & Worldwide Chairman of Innovative Medicine | $3.31M | 1964 | — |
| Joseph J. Wolk | Executive Vice President & Chief Financial Officer | $3.22M | 1967 | — |
| John C. Reed | Executive Vice President of Innovative Medicine and R&D | $3.17M | 1958 | — |
| Timothy Schmid | Executive Vice President & Worldwide Chairman of MedTech | $2.54M | 1970 | — |
| Kristen Blair Mulholland | Executive Vice President & Chief Human Resources Officer | $2.15M | 1967 | — |
| James Swanson | Executive Vice President & Chief Information Officer | — | 1967 | — |
| Elizabeth Forminard | Executive Vice President & Chief Legal Officer | — | 1972 | — |